Transplantation of Diabetes

Getting a new heart, liver, kidney, lung, or other organ can save your life. Sometimes, it can also lead to type 2 diabetes. Many people can stop taking steroids after 6 months or so. This may solve the problem. If scientists can develop safe immunosuppressant’s that always work, then many people with type 1 diabetes may choose to have pancreas transplants. Until then, many doctors think islet transplants are a better option even after performing clinical trials on islet transplants. Islets are clusters of cells in the pancreas that make insulin. In people with type 1 diabetes, islet cells are destroyed. Only 1-2% of the pancreas is made up of islet cells. In pancreatic islet transplantation, cells are taken from a donor pancreas and transferred into another person. Once implanted, the new islets begin to make and release insulin. Researchers hope that islet transplantation will help people with type 1 diabetes live without daily injections of insulin. A transplant of the pancreas is usually reserved for those with serious complications. Pancreas transplants are most often done when a patient also receives a new kidney. The pancreas transplant adds little further risk in this situation and offers big benefits. However, transplant surgery is risky. Each person needs to carefully weigh the potential benefits and risks. Xenotransplantation for the treatment of type 1 diabetes is the transplantation of living cells, tissues or organs from one species to another. Such cells, tissues or organs are called xenografts or xenotransplants. A bolus dose is insulin that is specifically taken at meal times to keep blood glucose levels under control following a meal. A bolus dose is insulin that is specifically taken at meal times to keep blood glucose levels under control following a meal. Bolus insulin needs to act quickly and so short acting insulin or rapid acting insulin will be used where as Conventional insulin therapy is a therapeutic regimen for treatment of diabetes mellitus which contrasts with the newer intensive insulin therapy.

  • Islet Cell Transplantation for Diabetes
  • Xenotransplantation for the Treatment of Type 1 Diabetes
  • New insights into beta cell signaling pathways
  • The role of non-beta cells in glucose homeostasis
  • Novel drug targets to preserve and/or promote proliferation of beta cells
  • Islet transplants
  • Pancreatic islet transplantation
  • Xenotransplantation
  • Bolus insulin
  • Conventional insulinotherapy
  • Pancreas Transplantation
  • Clinical Trial on Islet Transplants
  • Bolus insulin and Conventional Insulin

Related Conference of Transplantation of Diabetes

November 21-22, 2018

14th World Congress on Endocrinology & Diabetes

Paris, France
November 26-27, 2018

26th International Diabetes and Healthcare Conference

Helsinki, Finland
November 26-27, 2018

13th European Diabetes and Endocrinology Congress

Dublin, Ireland
February 27-28, 2019

Asia Pacific Diabetes and Endocrinology Congress

Radisson Hotel Narita, Tokyo, Japan

April 17-18, 2019

21st Asia Pacific Diabetes Conference

Osaka,Japan
May 17-18, 2019

2nd Global Experts Meeting on Diabetes, Hypertension & Metabolic Syndrome

Holiday Inn Singapore Atrium | Singapore
May 30-31, 2019

2nd Global Meeting on Diabetes and Endocrinology

Istanbul, Turkey
June 10-11, 2019

28th European Diabetes Congress

| Edinburgh, Scotland
July 24-25, 2019

29th World Diabetes & Heart Congress

Melbourne, Australia
July 29-30, 2019

12th International Conference on Diabetes & Metabolism

Chicago | Illinois| USA
Oct 03-04, 2019

Euro Diabetes Congress & Expo

| Paris, France

Transplantation of Diabetes Conference Speakers

Recommended Sessions

Related Journals

Are you interested in